IP Library Granted Patent US 9,700,620
Granted Patent B2
US 9,700,620 · App. 15/213,310 · Granted Jul 11, 2017

Polymeric nanocarriers with light-triggered release mechanism

Inventors: Adah Almutairi (La Jolla, CA); Mathieu Lessard-Viger (San Diego, CA); Wangzhong Sheng (La Jolla, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61K41/0028A61K9/0004A61K9/5031A61K9/5153A61N5/062A61N2005/0658
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,700,620
App. No.
15/213,310
Granted
Jul 11, 2017
Kind
B2
Abstract

Near infrared radiation at a wavelength that induces resonance in water is used to remotely activate thermal plasticization of polymeric particles to trigger the release of encapsulated molecules from the particles. Nanocarriers formed from biocompatible hydrophilic polymers may be used to deliver encapsulated molecules to tissue with a reversible transition that allows repeated activations for extended release of the payload.

Claims (12)

1. A method for delivering a payload, comprising:

encapsulating the payload in a nanocarrier comprising a hydrophilic polymer having no inherent light sensitivity, wherein the polymer is poly(lactic-co-glycolic) (PLGA);

hydrating the polymer to form nanodomains of water; and

exposing the nanocarrier to light having a wavelength corresponding to a water absorption band within the near infrared (NIR) region adapted to induce resonant photon interactions with the water to locally heat the polymer to induce a phase change in the polymer whereby the payload diffuses out of the nanocarrier.

2. The method of claim 1 , wherein the a wavelength is selected from the group consisting of 980 nm, 1200 nm, 1450 nm, and 1950 nm.

3. The method of claim 1 , wherein the PLGA has a lactide:glycolide ratio selected according to a desired release rate.

4. The method of claim 3 , wherein the lactide:glycolide ratio is selected from the group consisting of 50:50, 75:25, and 85:15.

5. The method of claim 3 , wherein the PLGA has a lactide:glycolide ratio selected according to a desired particle size.

6. The method of claim 5 , wherein the lactide:glycolide ratio is selected from the group consisting of 50:50, 75:25, and 85:15.

7. The method of claim 1 , wherein the payload comprises a therapeutic compound.

8. The method of claim 1 , wherein the payload comprises a dye.

9. The method of claim 1 , further comprising forming an aggregation of nanocarriers for delivery of the payload over an extended period of time.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: SHENG, WANGZHONG
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 042170/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2017
From: ALMUTAIRI, ADAH; LESSARD-VIGER, MATHIEU
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 041971/0868 →
CONFIRMATORY LICENSE Recorded Nov 16, 2016
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040692/0930 →
Continuity (3)
Division 14424963
Provisional Application 61694179 · Aug 28, 2012
Related Publication 20160324966A1 · Nov 10, 2016